65 Equity Partners makes first European deal with HAS

The firm will also back HAS’ planned acquisition of Cerbios-Pharma.

31 March 2025•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.